0 citations0 references

Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)

British Journal of Dermatology2018Vol. 178(5), pp. e332–e341

Citations Over TimeTop 1% of 2018 papers

Joanne R Chalmers, Kim S Thomas, Christian Apfelbacher, Hywel C Williams, C.A.C. Prinsen, Phyllis I. Spuls, E. Simpson, Louise A. A. Gerbens, Maarten Boers, S. Barbarot, J.F. Stalder, Katrina Abuabara, Valéria Aoki, Marius Ardeleanu, John Armstrong, B K Bang, Teresa Løvold Berents, Tim Burton, Lisa Butler, T. Chubachi, Amanda Cresswell-Melville, Amy M. DeLozier, Laurent Eckert, Lawrence F. Eichenfield, Carsten Flohr, Masaki Futamura, A. Gadkari, Eli Synnøve Gjerde, Karlijn F. van Halewijn, Carol Hawkes, Laura Howells, L Howie, Rosemary Humphreys, Henrique Akira Ishii, Yoko Kataoka, Ichiro Katayama, Wim Kouwenhoven, Sinéad Langan, Yael A. Leshem, Stéphanie Mérhand, Paola Mina‐Osorio, Hiroyuki Murota, T. Nakahara, Fabio P. Nunes, Uffe Nygaard, Michaela Nygårdas, Yukihiro Ohya, Emi Ono, Eckard Rehbinder, Natasha K Rogers, Geertruida L. E. Romeijn, Marie L. A. Schuttelaar, Alison Sears, Michael A. Simpson, Jasvinder A. Singh, Jerome Srour, Beth Stuart, Åke Svensson, G. Talmo, H. Vestby Talmo, Henrique D. Teixeira, Jacob P. Thyssen, Gail Todd, F. Torchet, Annika Volke, Laura von Kobyletzki, Elke Weißhaar, A. Wollenberg, M. Zaniboni

Abstract

This is the report from the fifth meeting of the Harmonising Outcome Measures for Eczema initiative (HOME V). The meeting was held on 12-14 June 2017 in Nantes, France, with 81 participants. The main aims of the meeting were (i) to achieve consensus over the definition of the core domain of long-term control and how to measure it and (ii) to prioritize future areas of research for the measurement of the core domain of quality of life (QoL) in children. Moderated whole-group and small-group consensus discussions were informed by presentations of qualitative studies, systematic reviews and validation studies. Small-group allocations were performed a priori to ensure that each group included different stakeholders from a variety of geographical regions. Anonymous whole-group voting was carried out using handheld electronic voting pads according to predefined consensus rules. It was agreed by consensus that the long-term control domain should include signs, symptoms, quality of life and a patient global instrument. The group agreed that itch intensity should be measured when assessing long-term control of eczema in addition to the frequency of itch captured by the symptoms domain. There was no recommendation of an instrument for the core outcome domain of quality of life in children, but existing instruments were assessed for face validity and feasibility, and future work that will facilitate the recommendation of an instrument was agreed upon.

Citations Over TimeTop 1% of 2018 papers

Abstract

Related Papers